Using methylation profiling to diagnose systemic metastases of pleomorphic xanthoastrocytoma.
Document Type
Article
Publication Date
1-2020
Publication Title
Neuro-oncology advances
Abstract
New methods of molecular testing are improving diagnostic accuracy and reliability beyond what the traditional light microscope can provide. In the current case, methylome profiling and next-generation sequencing were used to prove that tumors in the chest wall and spine were metastases from what, by histology, appeared to be a low-grade cerebral glioma. They also identified a targetable BRAF V600E mutation that dictated subsequent therapy, to which the patient responded.
Volume
2
Issue
1
First Page
vdz057
Recommended Citation
Kam KL, Snuderl M, Khan O, Wolinsky JP, Gondi V, Grimm S, Horbinski C. Using methylation profiling to diagnose systemic metastases of pleomorphic xanthoastrocytoma. Neurooncol Adv. 2020 Jan-Dec;2(1):vdz057. doi: 10.1093/noajnl/vdz057. Epub 2019 Dec 27. PMID: 32002518; PMCID: PMC6978194.
DOI
10.1093/noajnl/vdz057
ISSN
2632-2498
PubMed ID
32002518